World Journal of Stem Cells - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10921)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

497

WORD

136

HTML

5609

Figures (1-4)

829

Sum=7071

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

416

Download

1421

Sum=1837

Publishing Process of This Article

Item

Count

Browse

573

Download

1440

Sum=2013

Jun 26, 2021 (publication date) through Nov 14, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Eksi YE, Sanlioglu AD, Akkaya B, Ozturk BE, Sanlioglu S. Genome engineering and disease modeling via programmable nucleases for insulin gene therapy: Promises of CRISPR/Cas9 technology . World J Stem Cells 2021; 13(6): 485-502 [PMID: 34249224 DOI: 10.4252/wjsc.v13.i6.485]
URL:	https://www.wjgnet.com/1948-0210/full/v13/i6/485.htm

Number	Citing Articles
1	Busra Cetin, Fulya Erendor, Yunus E. Eksi, Ahter D. Sanlioglu, Salih Sanlioglu. Gene and cell therapy of human genetic diseases: Recent advances and future directions. Journal of Cellular and Molecular Medicine 2024; 28(17) doi: 10.1111/jcmm.70056
2	Mona Mohamed Ibrahim Abdalla. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges. World Journal of Gastroenterology 2024; 30(40): 4339-4353 doi: 10.3748/wjg.v30.i40.4339 Abstract(617) \| Core Tip(637) \| Full Article(HTML)(8958) \| Full Article with Cover (PDF)-1869K(154) \| Audio-1231K(20) \| Peer-Review Report-182K(95) \| Answering Reviewers-50K(100) \| Full Article (PDF)-1535K(255) \| Full Article (XML)-254K(99) \| Times Cited (7) \| Total Visits (13568) \| Open
3	Yunus Emre Eksi, Atil Bisgin, Ahter D. Sanlioglu, Reha Onur Azizoglu, Mustafa Kemal Balci, Thomas S. Griffith, Salih Sanlioglu. Cell Biology and Translational Medicine, Volume 18. Advances in Experimental Medicine and Biology 2022; 1409: 145 doi: 10.1007/5584_2022_746
4	Busra Cetin, Fulya Erendor, Yunus Emre Eksi, Ahter D. Sanlioglu, Salih Sanlioglu. Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects. Expert Reviews in Molecular Medicine 2025; 27 doi: 10.1017/erm.2025.10
5	Melike Aliciaslan, Ezgi Erbasan, Fulya Erendor, Salih Sanlioglu. Prime Editing: The Next Frontier in Precision Gene Therapy. The Journal of Gene Medicine 2025; 27(10) doi: 10.1002/jgm.70040
6	Zeyu Tian, Tao Yu, Jun Liu, Ting Wang, Akon Higuchi. Stem Cell in Medicine. Progress in Molecular Biology and Translational Science 2023; 199: 3 doi: 10.1016/bs.pmbts.2023.02.012
7	Jonathan Waataja, Sayeed Ikramuddin, Dov Gal, Charles Billington. Type 2 Diabetes in 2024 - From Early Suspicion to Effective Management. 2023; doi: 10.5772/intechopen.1002713
8	Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor, Ahter Dilsad Sanlioglu, Salih Sanlioglu. Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease. Gene Therapy 2025; doi: 10.1038/s41434-025-00575-0